Michael R Bishop

11PUBLICATIONS
77CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCourts and sentencing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 24, 2026
Late cytopenia after CD19 chimeric antigen receptor T cell in large B cell lymphoma: A Cell Therapy Consortium Analysis.

|Jun 11, 2026
Management of Bispecific Antibody Toxicities: A Focus on Multiple Myeloma.

|Jun 04, 2026
CAR T-cell Kinetics, Persistence, and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-cell ALL Treated with Obecabtagene Autoleucel in the FELIX Study.

|May 11, 2026
Low-Strength Type I Interferon Signaling Promotes CAR T-cell Treatment Efficacy.

|May 05, 2026
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma.

|Jun 24, 2025
Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCL.

Rakesh Awasthi, Stephan A Grupp, Edward R Waldron

Pageof 2

Frequent Collaborators

4 joint publications

Joseph P McGurik

3 joint publications

Stephen J Schuster

3 joint publications

Richard T Maziarz

3 joint publications

Peter A Riedell